These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7521090)

  • 1. Effect of dosing regimen on efficacy and safety of doxazosin in normotensive men with symptomatic prostatism: a pilot study.
    Kaplan SA; Soldo KA; Olsson CA
    Urology; 1994 Sep; 44(3):348-52. PubMed ID: 7521090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terazosin and doxazosin in normotensive men with symptomatic prostatism: a pilot study to determine the effect of dosing regimen on efficacy and safety.
    Kaplan SA; Soldo KA; Olsson CA
    Eur Urol; 1995; 28(3):223-8. PubMed ID: 8536776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxazosin in physiologically and pharmacologically normotensive men with benign prostatic hyperplasia.
    Kaplan SA; Meade-D'Alisera P; Quiñones S; Soldo KA
    Urology; 1995 Oct; 46(4):512-7. PubMed ID: 7571220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlation of maximal urinary flow rate and plasma doxazosin concentrations in the treatment of benign prostatic hyperplasia. Multicenter Study Group.
    Fawzy A; Vashi V; Chung M; Dias N; Gaffney M
    Urology; 1999 Feb; 53(2):329-35. PubMed ID: 9933049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study.
    Fawzy A; Braun K; Lewis GP; Gaffney M; Ice K; Dias N
    J Urol; 1995 Jul; 154(1):105-9. PubMed ID: 7539853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxazosin in benign prostatic hyperplasia: effects on blood pressure and urinary flow in normotensive and hypertensive men.
    Kirby RS
    Urology; 1995 Aug; 46(2):182-6. PubMed ID: 7542819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morning versus evening dosing with doxazosin in benign prostatic hyperplasia: pharmacokinetics, efficacy and safety.
    Kirby RS
    Int J Clin Pract; 1998 Mar; 52(2):75-7. PubMed ID: 9624784
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized double-blind study assessing 4 versus 8 mg. doxazosin for benign prostatic hyperplasia.
    MacDiarmid SA; Emery RT; Ferguson SF; McGuirt-Franklin R; McIntyre WJ; Johnson DE
    J Urol; 1999 Nov; 162(5):1629-32. PubMed ID: 10524884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 29-week doxazosin treatment in patients with symptomatic benign prostatic hyperplasia. A double-blind placebo-controlled study.
    Bendix Holme J; Christensen MM; Rasmussen PC; Jacobsen F; Nielsen J; Nørgaard JP; Olesen S; Noer I; Wolf H; Elkjaer Husted S
    Scand J Urol Nephrol; 1994 Mar; 28(1):77-82. PubMed ID: 7516576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical and flowmetric results of the treatment of benign prostatic hyperplasia with doxazosin].
    Salinas Casado J; Esteban Fuertes M; Virseda Chamorro M; Ramírez Fernández JC; Salomon Moh'd S; Luengo Alpuente S; Resel Estévez L
    Arch Esp Urol; 1999 Sep; 52(7):739-48. PubMed ID: 10540764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia.
    Andersen M; Dahlstrand C; Høye K
    Eur Urol; 2000 Oct; 38(4):400-9. PubMed ID: 11025377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxazosin for benign prostatic hyperplasia: long-term efficacy and safety in hypertensive and normotensive patients. The Multicenter Study Group.
    Lepor H; Kaplan SA; Klimberg I; Mobley DF; Fawzy A; Gaffney M; Ice K; Dias N
    J Urol; 1997 Feb; 157(2):525-30. PubMed ID: 8996348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia.
    Baldwin KC; Ginsberg PC; Roehrborn CG; Harkaway RC
    Urology; 2001 Aug; 58(2):203-9. PubMed ID: 11489700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.
    Chung BH; Hong SJ
    BJU Int; 2006 Jan; 97(1):90-5. PubMed ID: 16336335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement.
    de Reijke TM; Klarskov P
    BJU Int; 2004 Apr; 93(6):757-62. PubMed ID: 15049986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose titration study evaluating terazosin, a selective, once-a-day alpha 1-blocker for the treatment of symptomatic benign prostatic hyperplasia.
    Lepor H; Knapp-Maloney G; Sunshine H
    J Urol; 1990 Dec; 144(6):1393-7; discussion 1397-8. PubMed ID: 1700152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
    Gratzke P; Kirby RS
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of the doxazosin gastrointestinal therapeutic system for the treatment of benign prostate hyperplasia.
    Sun GH; Tsui KH; Wu TT; Chang CH; Cheng CL; Schou M
    Kaohsiung J Med Sci; 2010 Oct; 26(10):532-9. PubMed ID: 20950778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of doxazosin in normotensive and hypertensive patients with benign prostatic hyperplasia.
    Kirby RS
    Scand J Urol Nephrol Suppl; 1995; 168():29-33. PubMed ID: 7541549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.